INTEGRA LIFESCIENCES HOLDINGS CORP Research and Development Expense
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Research and Development Expense of $14.93 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2020-08-10
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development expense for the quarter ending 2020-06-30 was $14.93M, a 15.35% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development expense for the quarter ending 2020-03-31 was $20.82M, a 13.62% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development expense for the quarter ending 2019-09-30 was $19.00M, a 6.43% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development expense for the quarter ending 2019-06-30 was $17.63M, a 7.72% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development expense for fiscal 2018 was $78.04M, a 22.99% increase from fiscal 2017.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development expense for fiscal 2017 was $63.45M, a 9.11% increase from fiscal 2016.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development expense for fiscal 2016 was $58.16M, a 14.26% increase from fiscal 2015.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development expense for fiscal 2015 was $50.90M, a 16.84% increase from fiscal 2014.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | $14.93M 10-Q · filed 2020-08-10 | $35.74M 10-Q · filed 2020-08-10 | ||||||
| 2020-03-31 | $20.82M 10-Q · filed 2020-05-07 | |||||||
| 2019-09-30 | $19.00M 10-Q · filed 2019-10-25 | $36.64M derived: sum of 2 quarters · filed 2020-08-10 | $53.28M 10-Q · filed 2019-10-25 | $75.26M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-06-30 | $17.63M 10-Q · filed 2020-08-10 | $35.95M 10-Q · filed 2020-08-10 | $56.25M derived: sum of 3 quarters · filed 2020-08-10 | $76.56M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $18.32M 10-Q · filed 2020-05-07 | $38.62M derived: sum of 2 quarters · filed 2020-05-07 | $58.93M derived: sum of 3 quarters · filed 2020-05-07 | $78.04M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $20.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $40.61M derived: sum of 2 quarters · filed 2019-10-25 | $59.72M derived: sum of 3 quarters · filed 2019-10-25 | $78.04M 10-K · filed 2019-02-26 | ||||
| 2018-09-30 | $20.31M 10-Q · filed 2019-10-25 | $39.42M derived: sum of 2 quarters · filed 2019-10-25 | $57.74M 10-Q · filed 2019-10-25 | $74.92M derived: sum of 4 quarters · filed 2019-10-25 | ||||
| 2018-06-30 | $19.11M 10-Q · filed 2019-07-25 | $37.43M 10-Q · filed 2019-07-25 | $54.61M derived: sum of 3 quarters · filed 2019-07-25 | $69.65M derived: sum of 4 quarters · filed 2019-07-25 | ||||
| 2018-03-31 | $18.32M 10-Q · filed 2019-04-29 | $35.51M derived: sum of 2 quarters · filed 2019-04-29 | $50.54M derived: sum of 3 quarters · filed 2019-04-29 | $66.29M derived: sum of 4 quarters · filed 2019-04-29 | ||||
| 2017-12-31 | $17.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $32.21M derived: sum of 2 quarters · filed 2019-02-26 | $47.96M derived: sum of 3 quarters · filed 2019-02-26 | $63.45M 10-K · filed 2019-02-26 | ||||
| 2017-09-30 | $15.03M 10-Q · filed 2018-11-01 | $30.78M derived: sum of 2 quarters · filed 2018-11-01 | $46.27M 10-Q · filed 2018-11-01 | $60.18M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $15.75M 10-Q · filed 2018-07-26 | $31.24M 10-Q · filed 2018-07-26 | $45.14M derived: sum of 3 quarters · filed 2019-02-26 | $60.27M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $15.49M 10-Q · filed 2018-04-26 | $29.39M derived: sum of 2 quarters · filed 2019-02-26 | $44.52M derived: sum of 3 quarters · filed 2019-02-26 | $59.20M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $13.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $29.02M derived: sum of 2 quarters · filed 2019-02-26 | $43.70M derived: sum of 3 quarters · filed 2019-02-26 | $58.16M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $15.12M 10-Q · filed 2017-10-26 | $29.80M derived: sum of 2 quarters · filed 2017-10-26 | $44.25M 10-Q · filed 2017-10-26 | $58.12M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $14.68M 10-Q · filed 2017-07-26 | $29.13M 10-Q · filed 2017-07-26 | $43.00M derived: sum of 3 quarters · filed 2018-03-01 | $56.93M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $14.45M 10-Q · filed 2017-04-26 | $28.32M derived: sum of 2 quarters · filed 2018-03-01 | $42.26M derived: sum of 3 quarters · filed 2018-03-01 | $54.27M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $13.87M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $27.80M derived: sum of 2 quarters · filed 2018-03-01 | $39.82M derived: sum of 3 quarters · filed 2018-03-01 | $50.90M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $13.94M 10-Q · filed 2016-10-28 | $25.95M derived: sum of 2 quarters · filed 2016-10-28 | $37.03M 10-Q · filed 2016-10-28 | $47.04M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $12.01M 10-Q · filed 2016-07-28 | $13.89M 10-Q · filed 2015-07-31 | $23.09M 10-Q · filed 2016-07-28 | $26.45M 10-Q · filed 2015-07-31 | $33.10M derived: sum of 3 quarters · filed 2017-02-23 | $44.23M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-31 | $11.08M 10-Q · filed 2016-04-27 | $12.56M 10-Q · filed 2015-05-01 | $21.09M derived: sum of 2 quarters · filed 2017-02-23 | $32.22M derived: sum of 3 quarters · filed 2017-02-23 | $45.97M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $10.01M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $21.14M derived: sum of 2 quarters · filed 2017-02-23 | $34.89M derived: sum of 3 quarters · filed 2017-02-23 | $43.56M 10-K · filed 2017-02-23 | $51.60M 10-K · filed 2015-02-27 | |||
| 2014-09-30 | $11.13M 10-Q · filed 2015-11-04 | $13.13M 10-Q · filed 2014-11-07 | $24.88M derived: sum of 2 quarters · filed 2015-11-04 | $33.55M 10-Q · filed 2015-11-04 | $39.44M 10-Q · filed 2014-11-07 | $42.49M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2014-06-30 | $13.74M 10-Q · filed 2015-07-31 | $26.31M 10-Q · filed 2015-07-31 | $31.36M derived: sum of 3 quarters · filed 2016-02-26 | $44.41M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $12.57M 10-Q · filed 2015-05-01 | $17.61M derived: sum of 2 quarters · filed 2016-02-26 | $30.66M derived: sum of 3 quarters · filed 2016-02-26 | $42.47M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $18.10M derived: sum of 2 quarters · filed 2016-02-26 | $29.91M derived: sum of 3 quarters · filed 2016-02-26 | $42.62M 10-K · filed 2016-02-26 | $52.09M 10-K · filed 2014-02-27 | |||
| 2013-09-30 | $13.05M 10-Q · filed 2014-11-07 | $24.86M derived: sum of 2 quarters · filed 2014-11-07 | $37.58M 10-Q · filed 2014-11-07 | $50.44M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $11.81M 10-Q · filed 2014-08-05 | $24.52M 10-Q · filed 2014-08-05 | $37.39M derived: sum of 3 quarters · filed 2015-02-27 | $50.49M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $12.72M 10-Q · filed 2014-05-01 | $25.58M derived: sum of 2 quarters · filed 2015-02-27 | $38.69M derived: sum of 3 quarters · filed 2015-02-27 | $51.82M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $12.86M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $25.97M derived: sum of 2 quarters · filed 2015-02-27 | $39.10M derived: sum of 3 quarters · filed 2015-02-27 | $51.01M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $13.11M 10-Q · filed 2013-10-30 | $26.24M derived: sum of 2 quarters · filed 2013-10-30 | $38.15M 10-Q · filed 2013-10-30 | $51.55M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-06-30 | $13.13M 10-Q/A · filed 2013-08-02 | $25.04M 10-Q/A · filed 2013-08-02 | $38.45M derived: sum of 3 quarters · filed 2014-06-20 | $51.63M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-03-31 | $11.91M 10-Q · filed 2013-05-02 | $25.31M derived: sum of 2 quarters · filed 2014-06-20 | $38.50M derived: sum of 3 quarters · filed 2014-06-20 | $51.21M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2011-12-31 | $13.40M derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $26.59M derived: sum of 2 quarters · filed 2014-06-20 | $39.30M derived: sum of 3 quarters · filed 2014-06-20 | $51.45M 8-K · filed 2014-06-20 | ||||
| 2011-09-30 | $13.19M 10-Q · filed 2012-10-24 | $25.90M derived: sum of 2 quarters · filed 2012-10-24 | $38.05M 10-Q · filed 2012-10-24 | $51.38M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $12.71M 10-Q · filed 2012-07-31 | $24.86M 10-Q · filed 2012-07-31 | $38.19M derived: sum of 3 quarters · filed 2013-02-26 | $49.91M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $12.15M 10-Q · filed 2012-04-26 | $25.48M derived: sum of 2 quarters · filed 2013-02-26 | $37.20M derived: sum of 3 quarters · filed 2013-02-26 | $48.97M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $13.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $25.05M derived: sum of 2 quarters · filed 2013-02-26 | $36.81M derived: sum of 3 quarters · filed 2013-02-26 | $48.11M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $11.72M 10-Q · filed 2011-10-31 | $23.48M derived: sum of 2 quarters · filed 2011-10-31 | $34.78M 10-Q · filed 2011-10-31 | $46.59M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-06-30 | $11.76M 10-Q · filed 2011-08-01 | $23.06M 10-Q · filed 2011-08-01 | $34.87M derived: sum of 3 quarters · filed 2012-02-27 | $46.40M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-03-31 | $11.30M 10-Q · filed 2011-04-28 | $23.11M derived: sum of 2 quarters · filed 2012-02-27 | $34.64M derived: sum of 3 quarters · filed 2012-02-27 | $44.94M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2009-12-31 | $11.81M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $23.34M derived: sum of 2 quarters · filed 2012-02-27 | $33.64M derived: sum of 3 quarters · filed 2012-02-27 | $44.28M 10-K · filed 2012-02-27 | ||||
| 2009-09-30 | $11.53M 10-Q · filed 2010-10-28 | $21.83M derived: sum of 2 quarters · filed 2010-10-28 | $32.47M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $10.30M 10-Q · filed 2010-07-29 | $20.95M 10-Q · filed 2010-07-29 | ||||||
| 2008-12-31 | $60.49M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |